SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER

被引：0
|
作者：
Kashiwagi, S. [1 ]
Yashiro, M. [1 ]
Aomatsu, N. [1 ]
Kawajiri, H. [1 ]
Takashima, T. [1 ]
Onoda, N. [1 ]
Ishikawa, T. [1 ]
Hirakawa, K. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] IGFR as a candidate therapeutic target for cancer-initiating cells in triple-negative breast cancer
    Ueno, Naoto T.
    Kai, Kazuharu
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [42] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    ONCOLOGY-NEW YORK, 2017, 31 : 13 - 20
  • [43] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    ONCOLOGY-NEW YORK, 2017, 31 (02): : 130 - 137
  • [44] Therapeutic targets of triple-negative breast cancer: a review
    Jamdade, Vinayak S.
    Sethi, Nikunj
    Mundhe, Nitin A.
    Kumar, Parveen
    Lahkar, Mangala
    Sinha, Neeraj
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (17) : 4228 - 4237
  • [45] Promising therapeutic options in triple-negative breast cancer
    Bilici, A.
    Arslan, C.
    Altundag, K.
    JOURNAL OF BUON, 2012, 17 (02): : 209 - 222
  • [46] Advances in Therapeutic Approaches for Triple-Negative Breast Cancer
    Mahtani, Reshma
    Kittaneh, Muaiad
    Kalinsky, Kevin
    Mamounas, Eleftherios
    Badve, Sunil
    Vogel, Charles
    Lower, Elyse
    Schwartzberg, Lee
    Pegram, Mark
    CLINICAL BREAST CANCER, 2021, 21 (05) : 383 - 390
  • [47] Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
    Corkery, B.
    Crown, J.
    Clynes, M.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 862 - 867
  • [48] RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
    My-my Huynh
    Jayanthan, Aarthi
    Pambid, Mary Rose
    Los, Gerrit
    Dunn, Sandra E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (01) : 1 - 5
  • [49] Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
    Liu, Jeff C.
    Granieri, Letizia
    Shrestha, Mariusz
    Wang, Dong-Yu
    Vorobieva, Ioulia
    Rubie, Elizabeth A.
    Jones, Rob
    Ju, YoungJun
    Pellecchia, Giovanna
    Jiang, Zhe
    Palmerini, Carlo A.
    Ben-David, Yaacov
    Egan, Sean E.
    Woodgett, James R.
    Bader, Gary D.
    Datti, Alessandro
    Zacksenhaus, Eldad
    CELL REPORTS, 2018, 23 (01): : 112 - 126
  • [50] Fatty acid synthase inhibition as a potential therapeutic target in triple-negative breast cancer
    Giro, A.
    Blancafort, A.
    Oliveras, G.
    Perez-Bueno, F.
    Dorca, J.
    Vinas, G.
    Puig, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S180 - S180
12345